依诺肝素在经皮冠状动脉介入术中的应用
王天松,吕树铮,陈韵岱
摘要(Abstract)：
关键词(KeyWords)：
基金项目(Foundation):
作者(Author): 王天松,吕树铮,陈韵岱
参考文献(References)：
- 1AntmanEM ,McCabeCH ,GurfinkelE ,etal.Enoxaparinpreventsdeathandcardiacischemiceventsinunstableangina/nonQ wavemyocardialinfarction.ResultsofThrombolysisInMyocardialInfarction(TIMI)11Btrial.Circulation,1999,100:15931601.
- 2CohenM ,DemersC ,GurfinkelEP ,etal.TheEfficacyandSafetyofSubcutaneousEnoxaparininNonQ WaveCoronaryEventsStudyGroup.Acomparisonoflowmolecularweightheparinwithunfractionatedheparinforunstablecoronaryarterydisease.NEnglJMed,1997,337:447452.
- 3Thethrombolysisinmyocardialinfarction(TIMI )11Atrialinvestigators.Dose rangingtrialofenoxaparinforunstableangina:resultsofTIMI 11A .JACC ,1997,29:14741482.
- 4ColletJP ,MontalescotG ,LisonL ,etal.Percutaneouscoronaryinterventionaftersubcutaneousenoxaparinpretreatmentinpatientswithunstableanginapectoris.Circulation,2001,103:658663.
- 5MartinJL ,FryET ,SanderinkGJ,etal.Reliableanticoagulationwithenoxaparininpatientsundergoingpercutaneouscoronaryintervention:ThepharmacokineticsofenoxaparininPCI (PEPCI)study.CatheterCardiovascInterv,2004,61:163170.
- 6MillerL ,GuptaA ,BertoletBD .Useofclopidogrelloading,enoxaparin,anddouble boluseptifibatideinthesettingofearlypercutaneouscoronaryinterventionforacutecoronarysyndromes.JInvasiveCardiol,2002,14:247250.
- 7KereiakesDJ,GrinesC ,FryE ,etal.Enoxaparinandabciximabadjunctivepharmacotherapyduringpercutaneouscoronaryintervention.JInvasiveCardiol,2001,13:272278.
- 8ChoussatR ,MontalescotG ,ColletJP ,etal.Aunique,lowdoseofintravenousenoxaparininelectivepercutaneouscoronaryintervention.JAmCollCardiol,2002,40:19431950.
- 9BhattDL ,LeeBI,CasterellaPJ,etal.Safetyofconcomitanttherapywitheptifibatideandenoxaparininpatientsundergoingpercutaneouscoronaryintervention:resultsoftheCoronaryRevascularizationUsingIntegrilinandSinglebolusEnoxaparinStudy.JAmCollCardiol,2003,41:2025.
- 10GaleoteG ,HusseinM ,SobrinoN ,etal.Useofenoxaparinorunfractionatedheparinandabciximabduringpercutaneouscoronaryinterventions:arandomisedpilotstudy.RevEspCardiol,2002,55:12611266.
- 11HrishJ,WarkentinTE ,ShaughnessySG ,etal.Heparinandlow molecular weightheparin:mechanismofaction,pharmacokinetics,dosing,monitoring,efficacy,andsafety.Chest,2001,119:645694.